Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response

Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review

(2013) Ana Requena-Méndez et al.   Expert Review of Anti-Infective Therapy

Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic setting

(2013) Luis Izquierdo et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Hypercoagulability biomarkers in Trypanosoma cruzi-infected patients

(2011) Dolors Tassies et al.   THROMBOSIS AND HAEMOSTASIS

The plasmin–antiplasmin system: structural and functional aspects

(2010) Johann Schaller et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Stroke in Asymptomatic Trypanosoma cruzi-Infected Patients

(2010) Francisco Javier Carod-Artal et al.   CEREBROVASCULAR DISEASES

Inflammatory and Prothrombotic Activation With Conserved Endothelial Function in Patients With Chronic, Asymptomatic Chagas Disease

(2010) Ramón N. Herrera et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Chagas disease: A Latin American health problem becoming a world health problem

(2009) Gabriel A. Schmunis et al.   ACTA TROPICA

Chagas disease in Spain, the United States and other non-endemic countries

(2009) Joaquim Gascon et al.   ACTA TROPICA

The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives

(2009) Antoniana Ursine Krettli   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)

(2008) Jose Antonio Marin-Neto et al.   AMERICAN HEART JOURNAL

Soluble P-selectin as a marker of in vivo platelet activation

(2008) Patrizia Ferroni et al.   CLINICA CHIMICA ACTA